Affordable Access

Publisher Website

The story of gefitinib, an EGFR kinase that works in lung cancer

Authors
Publisher
Elsevier Ltd
Publication Date
Volume
9
Issue
14
Identifiers
DOI: 10.1016/s1359-6446(04)03194-0
Keywords
  • News

Abstract

The reports that gefitinib (also known as Iressa/ZD1839) can treat human lung cancers is unfolding as one of the big stories in drug discovery.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

The story of gefitinib, an EGFR kinase that works...

on Drug Discovery Today Jul 15, 2004

EGFR mutation and response of lung cancer to gefit...

on New England Journal of Medicin... May 19, 2005

Gefitinib, an EGFR tyrosine kinase inhibitor, acti...

on Journal of B.U.ON. : official... 2014
More articles like this..